Abstract:Using ultrasound activating contrast agents to induce sonoporation is a potential strategy for effective lesion-targeted gene delivery. Previous reports have proven that submicron nanodroplets have a better advantage than microbubbles in that they can pass through tumor vasculature endothelial gaps by passive targeting; however, they cannot achieve an adequate dose in tumors to facilitate ultrasound-enhanced gene delivery. Additionally, a few studies focused on delivering macromolecular genetic materials (i.e.overexpression plasmid and CRISPR plasmid) have presented more unique advantages than small-molecular genetic materials (i.e.miRNA mimics, siRNA and shRNAetc.), such as enhancing the expression of target genes with long-term effectiveness. Thereby, we constructed novel plasmid-loadable magnetic/ultrasound-responsive nanodroplets, where superparamagnetic iron oxide nanoparticle dispersed perfluoropentane was encapsulated with lipids to which plasmids could be adhered, and branched polyethylenimine was used to protect the plasmids from enzymolysis. Furthermore,in vitroandin vivostudies were performed to verify the magnetic tumor-targeting ability of the plasmid-loadable magnetic/ultrasound-responsive nanodroplets and focused ultrasound enhanced intracellular plasmid delivery. The plasmid-loadable magnetic/ultrasound-responsive nanodroplets, carrying 16-19 plasmids per droplet, had desirable diameters less than 300 nm, and integrated the merits of excellent magnetic targeting capabilities and phase transition sensitivity to focused ultrasound. Under programmable focused ultrasound exposure, the plasmid-loadable magnetic/ultrasound-responsive nanodroplets underwent a phase-transition into echogenic microbubbles and the subsequent inertial cavitation of the microbubbles achieved an similar to 40%in vitroplasmid delivery efficiency. Following intravenous administration, T2-weighted magnet resonance imaging, scanning electron microscopy and inductively coupled plasma optical emission spectrometry of the tumors showed significantly enhanced intratumoral accumulation of the plasmid-loadable magnetic/ultrasound-responsive nanodroplets under an external magnetic field. And a GFP ELISA assay and immunofluorescence staining indicated that focused ultrasound-induced inertial cavitation of the plasmid-loadable magnetic/ultrasound-responsive nanodroplets significantly enhanced the intracellular delivery of plasmids within the tumor after magnet-assisted accumulation, while only lower GFP levels were observed in the tumors on applying focused ultrasound or an external magnet alone. Taken together, utilizing the excellent plasmid-loadable magnetic/ultrasound-responsive nanodroplets combined with magnetism and ultrasound could efficiently deliver plasmids to cancer cells, which could be a potential strategy for macromolecular genetic material delivery in the clinic to treat cancer.

Ultrasound-Triggered Phase-Transition Cationic Nanodroplets for Enhanced Gene Delivery

Polydopamine-based Nanoparticles with Excellent Biocompatibility for Photothermally Enhanced Gene Delivery

Ultrasound-Enhanced Reactive Oxygen Species Responsive Charge-Reversal Polymeric Nanocarriers for Efficient Pancreatic Cancer Gene Delivery.

Photothermal-Enhanced Phase-Transition Nanodroplets for Ultrasound-Mediated Diagnosis and Gene Transfection.

Ph-Responsive Polydopamine Nanoparticles for Photothermally Promoted Gene Delivery

DNA-loaded Microbubbles with Crosslinked Bovine Serum Albumin Shells for Ultrasound-Promoted Gene Delivery and Transfection

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Targeted Ultrasound-Triggered Phase Transition Nanodroplets for Her2-Overexpressing Breast Cancer Diagnosis and Gene Transfection.

Ultrasound Triggered Phase-Change Nanodroplets for Doxorubicin Prodrug Delivery and Ultrasound Diagnosis: an in Vitro Study.

Plasmid-loadable magnetic/ultrasound-responsive nanodroplets with a SPIO-NP dispersed perfluoropentane core and lipid shell for tumor-targeted intracellular plasmid delivery

Efficient, Dual-Stimuli Responsive Cytosolic Gene Delivery Using a RGD Modified Disulfide-Linked Polyethylenimine Functionalized Gold Nanorod.

Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors

Ultrasound-Assisted Mir-122-loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy

Polydopamine Nanoparticles/peg Composite Hydrogel for Controlled Drug Release and Combined Chemo-Photothermal Therapy

Self-assembled CaP-based Hybrid Nanoparticles to Enhance Gene Transfection Efficiency in Vitro and in Vivo: Beneficial Utilization of PEGylated Bisphosphate and Nucleus Locating Signal

DOTAP-Incorporated PEG-PLGA Nanoparticles for Efficient in Vitro and in Vivo Gene Delivery.

Tunable membrane-penetrating bioreductive nanogels based on guanidinylated dendrimers for programmable gene delivery

Ultrasound-targeted Microbubbles Combined with a Peptide Nucleic Acid Binding Nuclear Localization Signal Mediate Transfection of Exogenous Genes by Improving Cytoplasmic and Nuclear Import

Novel cationic 6-lauroxyhexyl lysinate modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance gene transfection.

Nanomaterials Optimized to improve delivery efficiency for gene therapy

Terminal Pegylated Dna-Gold Nanoparticle Conjugates Offering High Resistance to Nuclease Degradation and Efficient Intracellular Delivery of Dna Binding Agents